The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis

References

• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115:1531–1543. doi:10.1002/cncr.24121.
   PubMed Web of Science ®Google Scholar
• Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005;23:2004–2011. doi:10.1200/jco.2005.06.031.
   PubMed Web of Science ®Google Scholar
• Bishop MW, Janeway KA, Gorlick R. Future directions in the treatment of osteosarcoma. Curr Opin Pediatr. 2016;28:26–33. doi:10.1097/mop.0000000000000298.
   PubMed Web of Science ®Google Scholar
• Biazzo A, De Paolis M. Multidisciplinary approach to osteosarcoma. Acta Orthop Belg. 2016;82:690–698.
   PubMed Web of Science ®Google Scholar
• Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res. 2009;152:15–32. doi:10.1007/978-1-4419-0284-9_2.
   PubMedGoogle Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452–463. doi:10.1016/j.ccell.2016.03.010.
   PubMed Web of Science ®Google Scholar
• Guttman M, Russell P, Ingolia NT, Weissman JS, Lander ES. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell. 2013;154:240–251. doi:10.1016/j.cell.2013.06.009.
   PubMed Web of Science ®Google Scholar
• Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–166. doi:10.1146/annurev-biochem-051410-092902.
   PubMed Web of Science ®Google Scholar
• Li JP, Liu LH, Li J, Chen Y, Jiang XW, Ouyang YR, Liu YQ, Zhong H, Li H, Xiao T. Microarray expression profile of long noncoding RNAs in human osteosarcoma. Biochem Biophys Res Commun. 2013;433:200–206. doi:10.1016/j.bbrc.2013.02.083.
   PubMed Web of Science ®Google Scholar
• Liu K, Huang J, Ni J, Song D, Ding M, Wang J, Huang X, Li W. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p. Cell Cycle. 2017;16:578–587. doi:10.1080/15384101.2017.1288324.
   PubMed Web of Science ®Google Scholar
• Cai W, Wu B, Li Z, He P, Wang B, Cai A, Zhang X. LncRNA NBR2 inhibits epithelial-mesenchymal transition by regulating Notch1 signaling in osteosarcoma cells. J Cell Biochem. 2018. doi:10.1002/jcb.27508.
   Google Scholar
• Wang Y, Xue D, Li Y, Pan X, Zhang X, Kuang B, Zhou M, Li X, Xiong W, Li G, et al. The long noncoding RNA MALAT-1 is a novel biomarker in various cancers: a meta-analysis based on the GEO Database and Literature. J Cancer. 2016;7:991–1001. doi:10.7150/jca.14663.
   PubMed Web of Science ®Google Scholar
• Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653–668. doi:10.1016/j.ccell.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Di Cecilia S, Zhang F, Sancho A, Li S, Aguilo F, Sun Y, Rengasamy M, Zhang W, Del Vecchio L, Salvatore F, et al. RBM5-AS1 Is critical for self-renewal of colon cancer stem-like cells. Cancer Res. 2016;76:5615–5627. doi:10.1158/0008-5472.can-15-1824.
   PubMedGoogle Scholar
• Wang Y, Qian CY, Li XP, Zhang Y, He H, Wang J, Chen J, Cui JJ, Liu R, Zhou H, et al. Genome-scale long noncoding RNA expression pattern in squamous cell lung cancer. Sci Rep. 2015;5:11671. doi:10.1038/srep11671.
   PubMed Web of Science ®Google Scholar
• Zhao W, Dong S, Duan B, Chen P, Shi L, Gao H, Qi H. HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy. Am J Transl Res. 2015;7:1295–1302.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zeng X, Wang N, Zhao W, Zhang X, Teng S, Zhang Y, Lu Z. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Mol Cancer. 2018;17:89. doi:10.1186/s12943-018-0837-6.
   PubMed Web of Science ®Google Scholar
• Li Z, Dou P, Liu T, He S. Application of Long Noncoding RNAs in Osteosarcoma: biomarkers and Therapeutic Targets. Cell Physiol Biochem. 2017;42:1407–1419. doi:10.1159/000479205.
   PubMed Web of Science ®Google Scholar
• Yu T, Zhao Y, Hu Z, Li J, Chu D, Zhang J, Li Z, Chen B, Zhang X, Pan H, et al. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Res. 2017;77:5782–5794. doi:10.1158/0008-5472.can-17-0671.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P, Floros E, Dalamagas T, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44:D231–8. doi:10.1093/nar/gkv1270.
   PubMed Web of Science ®Google Scholar
• Han Z, Zhang Y, Sun Y, Chen J, Chang C, Wang X, Yeh S. ERbeta-mediated alteration of circATP2B1 and miR-204-3p signaling promotes invasion of clear cell renal cell carcinoma. Cancer Res. 2018;78:2550–2563. doi:10.1158/0008-5472.can-17-1575.
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Chun-Lin Z, Xiao-Long M, Lei Z. Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells. J Cell Physiol. 2018. DOI:10.1002/jcp.27435
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang R, Cheng G, Xu R, Han X. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells. Cell Cycle. 2018;17:1637–1648. doi:10.1080/15384101.2018.1489174.
   PubMed Web of Science ®Google Scholar
• Chan LH, Wang W, Yeung W, Deng Y, Yuan P, Mak KK. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression. Oncogene. 2014;33:4857–4866. doi:10.1038/onc.2013.433.
   PubMed Web of Science ®Google Scholar
• Bak RO, Mikkelsen JG. miRNA sponges: soaking up miRNAs for regulation of gene expression. Wiley Interdiscip Rev RNA. 2014;5:317–333. doi:10.1002/wrna.1213.
   PubMed Web of Science ®Google Scholar
• Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5:e944014. doi:10.4161/21541272.2014.944014.
   PubMedGoogle Scholar
• Kartha RV, Subramanian S. Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation. Front Genet. 2014;5:8. doi:10.3389/fgene.2014.00008.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344–352. doi:10.1038/nature12986.
   PubMed Web of Science ®Google Scholar
• Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y, Guo J. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014;4:6088. doi:10.1038/srep06088.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D, Wang T, Li X. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives. Oncotarget. 2016;7:13479–13490. doi:10.18632/oncotarget.7266.
   PubMed Web of Science ®Google Scholar
• Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, et al. NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity. 2018;48(107–19.e4). doi:10.1016/j.immuni.2017.12.007.
   Google Scholar
• Lou X, Han X, Jin C, Tian W, Yu W, Ding D, et al. SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention. OMICS. 2013;17:510–518. doi:10.1089/omi.2013.0058.
   PubMed Web of Science ®Google Scholar
• Wang J, Deng L, Huang J, Cai R, Zhu X, Liu F, Wang Q, Zhang J, Zheng Y. High expression of Fibronectin 1 suppresses apoptosis through the NF-kappaB pathway and is associated with migration in nasopharyngeal carcinoma. Am J Transl Res. 2017;9:4502–4511.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhuang J, Wang G, He S, Ni J, Xia W. MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression. Oncol Lett. 2017;14:7799–7806. doi:10.3892/ol.2017.7201.
   PubMed Web of Science ®Google Scholar
• Zhang H, Sun Z, Li Y, Fan D, Jiang H. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother. 2017;88:285–292. doi:10.1016/j.biopha.2017.01.023.
   PubMed Web of Science ®Google Scholar